Status | Study |
Completed |
Study Name: NI-0801 in Allergic Contact Dermatitis Condition: Allergic Contact Dermatitis Date: 2010-11-16 Interventions: Drug: Placebo single i.v. admi |
Completed |
Study Name: Study of the Intradermal Injection of rHuPH20 or Placebo in Subjects With Nickel Allergic Contact Dermatitis Condition: Dermatitis, Allergic Contact Date: 2009-06-25 Interventions: Drug: rHuPH20 ID syringe push bolus injection of either rHuPH20 or placebo control. Each injection will |
Completed |
Study Name: Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis Condition: Allergic Contact Dermatitis Date: 2009-03-22 Interventions: Drug: MRX-6 b.i.d treatment fo |
Completed |
Study Name: Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis Condition: Dermatitis Date: 2008-04-23 Interventions: Drug: tacrolimus ointment topi |
Completed |
Study Name: Multi-Centre European Photopatch Test Study Condition: Dermatitis, Photocontact Date: 2007-09-13 Interventions: Drug: 19 organic sunscreen filters and 5 topical NSAIDs Other Names: Bu |
Completed |
Study Name: Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation Condition: Allergic Contact Dermatitis Date: 2007-03-07 |
Completed |
Study Name: Quaternium-15, Use Test Condition: Allergic Contact Dermatitis Towards Quaternium-15 Date: 2006-04-04 Interventions: Drug: T.R.U.E.Test |
Completed |
Study Name: Immune Responses to BCG Vaccination in Malawi and the UK Condition: Immunity, Cellular Hypersensitivity, Delayed Type Date: 2005-10-17 Interventions: Biological: BCG |
Completed |
Study Name: CP-481,715 Nickel Allergy Study. Condition: Dermatitis, Allergic Contact Date: 2005-08-30 Interventions: Drug: CP-481,715 |
Completed |
Study Name: Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate Condition: Allergic Contact Dermatitis Date: 2005-08-22 Interventions: Drug: Goldnatriomthiosulphate, MDBGN, parthenolide |